Lensar (LNSR) Return on Capital Employed (2020 - 2026)
Lensar (LNSR) reported Return on Capital Employed of 32.43% for Q1 2026, down 39.0% year-over-year from 53.17% in Q1 2025, and up 60.09% quarter-over-quarter from 81.27% in Q4 2025.
Lensar (LNSR) Return on Capital Employed (2020 - 2026) Analysis & Trends
Lensar (LNSR) has 7 years of Return on Capital Employed data on file, last reported at 32.43% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 32.43%, down 39.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 32.43% (down 39.0% YoY), and the FY2025 annual result was 86.88%, down 6673.0% from the prior year.
- Return on Capital Employed rose to 32.43% in Q1 2026 per LNSR's latest filing, from 81.27% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 18.67% in Q1 2024 and troughed at 81.27% in Q4 2025.
- A 5-year average of 36.36% and a median of 32.43% in 2026 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2025: Return on Capital Employed surged 2593 bps in 2023, then tumbled 5957 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 45.96% in 2022, then jumped by 55 bps to 20.87% in 2023, then retreated by 4 bps to 21.7% in 2024, then slumped by 275 bps to 81.27% in 2025, then surged by 60 bps to 32.43% in 2026.
- Business Quant data shows LNSR's Return on Capital Employed at 32.43% in Q1 2026, 81.27% in Q4 2025, and 60.57% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | -32.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.43% |
| Dec 31, 2025 | -81.27% |
| Sep 30, 2025 | -60.57% |
| Jun 30, 2025 | -35.13% |
| Mar 31, 2025 | -32.05% |
| Dec 31, 2024 | -21.70% |
| Sep 30, 2024 | -24.65% |
| Jun 30, 2024 | -24.59% |
| Mar 31, 2024 | -18.67% |
| Dec 31, 2023 | -20.87% |
| Sep 30, 2023 | -19.80% |
| Jun 30, 2023 | -27.29% |
| Mar 31, 2023 | -40.66% |
| Dec 31, 2022 | -45.96% |
| Sep 30, 2022 | -45.73% |
| Jun 30, 2022 | -48.80% |
| Mar 31, 2022 | -38.00% |
| Dec 31, 2021 | -33.55% |
| Sep 30, 2021 | -36.28% |
| Jun 30, 2021 | -32.37% |